For the 8th time speakers and guests were gathering in Berlin on the 6th and 7th November 2015 to discuss the latest developments in MDS and, specifically in this editions, AML. After the welcome speech by the two chairmen Prof. Uwe Platzbecker (Dresden) und Prof. Aristoteles Giagounidis (Düsseldorf), 16 contributions in seven thematically structured sessions provided insights into pathophysiology, diagnostics and prognosis as well as aspects relating to the therapy of MDS and acute leukemia.
The 2015 colloquium presented for the first time with a new session structure: besides five plenary sessions, two parallel workshops were offered. The workshops provided an overview on the diagnosis and prognosis of MDS (WS1) and AML (WS2) by including practical case discussions with real-time microscope sessions and a voting tool for the audience.
For the final session the organizers were very happy to welcome Prof. Ghulam Mufti from London and Prof. Gerhard Ehninger from Dresden who commented on their respective views on how we might treat MDS and AML in 20 years from now.
Overall more than 200 participants from 23 countries attended the MDS Colloquium in Berlin of which Germany, the UK, Spain, Switzerland, Turkey and Russia represented the nations with the proportionally biggest share of attendees.
A warm thank you for the successful outcome of the event goes to all organizers, speakers, and participants as well as the main sponsor Celgene.
Author: S. Gloaguen